Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
* Zevalin - Generic: Ibritumomab | * Zevalin - Generic: Ibritumomab | ||
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
| - | * Herceptin - Generic: Trastuzumab | + | * [[Herceptin]] - Generic: Trastuzumab |
* [[Iressa]] - Generic: Gefitinib | * [[Iressa]] - Generic: Gefitinib | ||
* [[Tarceva]] - Generic: Erlotinib | * [[Tarceva]] - Generic: Erlotinib | ||
Revision as of 14:37, 8 December 2010
Anti-CD20 Monoclonal Antibody
Epidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Antagonist
Vascular Endothelial Growth Factor Inhibitor
Vascular Endothelial Growth Factor Receptor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
